Barron’s spoke with Dave Moore, executive vice president of U.S. operations, about Wegovy as a pill, rather than an injection ...

Novo Nordisk's Wegovy, especially at higher doses, rivals Eli Lilly's Zepbound in weight loss. Read why NVO stock is a Strong ...

Danish drugmaker Novo Nordisk said it plans to make its new obesity pill available through telehealth platforms like Ro and ...

Popular weight loss drugs are now available at a discount for Costco shoppers without insurance. The deal comes from a ...

Novo Nordisk (NVO) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some ...

Novo Nordisk's and Eli Lilly's blockbuster weight-loss drugs should be the first medicines doctors reach for to treat obesity ...

To begin with, Novo Nordisk stock is resoundingly cheap right now. The 14-month RSI recently breached 30, which is about as ...

The owners of Novo Nordisk A/S and the Danish government are new anchor investors in what they say will become the world’s ...

Through the first half of the year, Novo Nordisk recorded net sales of 154.9 billion Danish kroner ($24.4 billion), 15% ...

Novo Nordisk ( NVO -0.66%) -- the original Ozempic stock -- jumped higher again Thursday after announcing results from a weight loss study that had patients taking its Wegovy GLP-1 weight loss drug ...

Novo Nordisk (NVO) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the ...

There is multidistrict litigation, or an MDL, in progress against pharmaceutical companies Novo Nordisk and Eli Lilly and Co. from parties allegedly suffering side effects caused by the active ...